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Abstract. 
Phosphorhydrazone dendrimers ended by PTA (1,3,5-triaza-7-phosphaadamantane) 
derivatives are used for the complexation of ruthenium. The corresponding complexes, either 
isolated (synthesized ex situ, i.e. preformed) or generated in situ are used as catalysts for the 
hydration of phenylacetylene in various conditions (ex situ or in situ, quantities, temperature, 
duration, co-catalyst or not, recycling). The same preformed complexes are tested for their 
interaction with supercoiled DNA, to afford relaxed DNA.  
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Dendrimers are hyperbranched macromolecules synthesized from a central core, using 
repetitive branching elements. Thanks to their step-by-step synthesis, they have a perfectly 
defined multifunctionalized structure, contrarily to that of polymers. The presence of multiple 
terminal functions, easily accessible, is certainly the most important characteristic of 
dendrimers, which enables their use in many different fields [1]. Different types of dendrimers 
exist, depending on the nature of their internal structure, which can be purely organic as for 
instance for PAMAM [2] and PPI [3] dendrimers, but also partly inorganic [4], such as 
carbosilane [5] and phosphorhydrazone [6] dendrimers. Specific terminal functions of 
dendrimers have to be chosen to fulfill specific properties. For instance in the case of 
phosphorhydrazone dendrimers, organometallic complexes [7] for catalysis [8-11], or water-
solubilizing functions for biology [12-15] have been synthesized. The use of the same 
dendrimers in radically different fields is an exception, but organometallic dendrimers ended 
by coordination complexes are interesting candidates in this topic [16]. Indeed, we have 
previously reported that poly(phosphorhydrazone) dendrimers ended by analogous (but not 
strictly identical) copper complexes of pyridineimine terminal ligands have catalytic 
properties [17], and are able to fight in vitro against various cancer cell lines [18,19]. 
An important question to observe dual properties with a same dendrimer is the solubility, in 
particular the solubility in aqueous media if one of the properties concerns biology. Water 
solubility is generally attained with most dendrimers when having charges (positive or 
negative) on the terminal functions [20,21]. We have previously reported the synthesis of 
phosphorhydrazone dendrimers functionalized by PTA (1,3,5-triaza-7-phosphaadamantane 
[22-26]), and preliminary catalysis experiments with the corresponding Ru complexes, 
synthesized ex situ (preformed) [27]. The structure of the free and complexed compounds 
previously synthesized is shown in Figure 1, from generations 1 to 3 of the dendrimers (G1, 
G2, G3, and G1-Ru12, G2-Ru24, G3-Ru48) and the monomers (M and M-Ru), together with the 
newly synthesized G0 and G0-Ru6. The PTA is linked to the dendrimers through the 
alkylation of one nitrogen atom, thus affording dendrimers which, are soluble in water media, 
in particular in the water/isopropanol mixtures in which the catalytic experiments were carried 
out [27].  
In this paper, we will report more insights in the catalytic properties of these dendrimers (the 
preformed complexes, or the free PTA-dendrimers to which the ruthenium is added in situ), 
and a preliminary biological experiment, concerning their interaction with supercoiled DNA, 




Figure 1. Monomer and dendrimers functionalized by PTA (M, G0, G1, G2, G3), and the 
corresponding ruthenium complexes (M-Ru, G0-Ru6, G1-Ru12, G2-Ru24, G3-Ru48). The 
linear representation is used, but these compounds have a tridimensional branched structure, 
as schematized on the right. 
 
2. Experimental 
2.1. General.  
All reactions were carried out under argon, using standard Schlenk techniques. All solvents 
were distilled (toluene, THF and ether over sodium/benzophenone, pentane over phosphorus 
pentoxide, and CH2Cl2 over CaH2), and degassed when phosphines were used. 1H, 13C, 31P 
NMR spectra were recorded with Bruker AC 200, AC 250, or DPX 300 spectrometers. 
References for NMR chemical shifts are 85% H3PO4 for 31P NMR, SiMe4 for 1H and 13C 
NMR. The numbering used for NMR assignments is depicted in Figure 2. Monomers M and 
M-Ru, dendrimers G1, G2, G3, G1-Ru12, G2-Ru24, and G3-Ru48 were synthesized as 
published [27], as well as compound 1-G0 [28]. 
 
2.2. Synthesis and characterization of 2-G0 
A solution of borane dimethyl sulfide-complex 1.0 M in dichloromethane (7 mL, 7 mmol) 
was added to a solution of 1-G0 (2 g, 2.32 mmol) in dichloromethane (80 mL) at 0°C and the 
mixture was left stirring overnight. When there was no more aldehyde, solvent was removed 
in vacuum and methanol was added till all solid was solubilized, and then was again 
evaporated. This procedure was repeated two times more to afford 2-G0 (2 g, 2.3 mmol, 99% 
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yield) as a white powder. 1H NMR (250 MHz, DMSO-d6) δ (ppm): 4.47 (d, JHH = 5.5 Hz, 
12H, CH2), 5.24 (t, JHH = 5.5 Hz, 6H, OH), 6.8 (d, JHH = 8.4 Hz, 12H, C2H), 7.20 (d, JHH = 
8.4 Hz, 12H, C3H). 31P{1H} NMR (81 MHz, DMSO-d6) δ ppm: 12.3 (s). 13C{1H} NMR (62.9 
MHz, DMSO-d6) δ (ppm): 62.17 (s, CH2OH), 120.01 (s, C2H), 127.59 (s, C3H), 139.36 (s, 
C4), 148.53 (s, C1). MS (DCI/NH3, positive, MeOH) m/z for C42H42N3O12P3: 874.3 [M+1]. 
 
2.3. Synthesis and characterization of 3-G0 
Thionyl chloride (8 mL, 0.109 mmol) was added dropwise to dendrimer 2-G0 (1.058 g, 1.2 
mmol) in solid state under stirring on an ice bath till dendrimer was dissolved and the mixture 
was left overnight. Toluene was added to the mixture and the excess of thionyl chloride was 
co-evaporated (3 times). The dendrimer was precipitated in THF:pentane (1:10) to afford 3-
G0 (1.09 g ,1.1 mmol, 92 % yield) as a white powder. 1H NMR (250 MHz, CDCl3) δ (ppm): 
4.59 (s, 12H, CH2Cl), 6.94 (d, JHH = 8.4 Hz, 12H, C2H), 7.25 (d, JHH = 8.4 Hz, 12H, C3H). 
31P{1H} NMR (81 MHz, CDCl3) δ (ppm): 12.2 (s). 13C{1H} NMR (62.9 MHz, CDCl3) δ 
(ppm): 45.59 (s, CH2Cl), 121.20 (s, C2H), 129.92 (s, C3H), 134.31 (s, C4), 150.31 (s, C1). MS 
(DCI/NH3, positive, CDCl3) m/z for C42H36Cl6N3O6P3: 984.2 [M+1]+. 
 
2.4. Synthesis and characterization of G0 
A solution of PTA (471 mg, 3 mmol) in MeOH (48 mL, degassed) was added to a solution of 
dendrimer 3-G0 (420 mg, 0.427 mmol) in THF (15 mL, degassed) and the mixture was let 
stirring at room temperature (31P-NMR monitoring, 1day). Solvents were removed in vacuum 
and the residue was washed with degassed THF (3 times) to afford G0 (820 mg, 0.425 mmol, 
99% yield) as a white powder. 1H NMR (250 MHz, DMSO-d6) δ (ppm): 3.72 (dd, JHH = 14 
Hz, JHP = 8 Hz, 12H, C7Ha), 3.85 (dd, JHH = 14 Hz, JHP = 12 Hz, 12H, C7Hb), 4.22 (br s, 24H, 
C5H2, C6H2), 4.36 (d, JHH = 13.5 Hz, 6H, C9Ha), 4.51 (d, JHH = 13.5 Hz, 6H, C9Hb), 4.82 (d, 
JHH = 10.6 Hz, 12H, C8Ha), 5.04 (d, JHH = 10.6 Hz, 12H, C8Hb), 7.01 (d, JHH = 7.5 Hz, 12H, 
C2H), 7.49 (d, JHH = 7.5 Hz, 12H, C3H). 31P{1H} NMR (101.25 MHz, DMSO-d6) δ (ppm): -
83.7 (s, PPTA), 8.3 (s, Pcore). 13C{1H} NMR (62.9 MHz, DMSO-d6) δ (ppm): 45.78 (d, JHP = 
20.5 Hz, C7H2), 52.26 (d, JHP = 20.5 Hz, C6H2), 64.09 (s, C5H2), 69.69 (s, C9H2), 79.20 (s, 
C8H2), 121.49 (s, C2H), 123.54 (s, C4), 135.12 (s, C3H), 151.39 (s, C1). 
 
2.5. Synthesis and characterization of G0-Ru6  
A solution of dichloro(p-cymene)ruthenium dimer ([RuCl2(p-cymene)]2, 304 mg, 0.496 
mmol) in a solvent mixture of THF:MeOH 1:4 (5 mL, degassed) (some drops of CH2Cl2 and 
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heating) was added to a solution of dendrimer G0 (334 mg, 0.174 mmol) in a solvent mixture 
of THF:MeOH (degassed) 1:4 (20 mL) and the mixture was left stirring 2 hours at room 
temperature. The solvents were removed in vacuum and the residue was washed several times 
with THF and CH2Cl2 to afford G0-Ru6 (448 mg, 0.111 mmol, 64% yield) as an orange 
powder. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 1.09 (d, JHH = 6.6 Hz, 36H, C16H3), 1.9 (s, 
18H, C10H3), 2.70 (m, 6H, C15H), 4.0-4.2 (m, 12H, C5H2), 4.2-4.8 (br m, 48H, C6H2, C7H2, 
C9H2), 5.06 (br s, 12H, C8Ha), 5.36 (br s, 12H, C8Hb), 5.9 (m, 24H, C12H, C13H), 6.96 (br d, 
JHH = 7.8 Hz, 12H, C2H), 7.44 (br s, 12H, C3H). 31P{1H} NMR (121. 5 MHz, DMSO-d6) δ 
(ppm): -18.1 (s, PPTA), 8.6 (s, Pcore). 13C{1H} NMR (75.5 MHz, DMSO-d6) δ (ppm): 18.34 (s, 
C10H3), 22.12 (s, C16H3), 30.50 (s, C15H), 45.57 (br d, JHP = 20.0 Hz, C7H2), 52.14 (m, C6H2), 
63.21 (br s, C5H2), 69.13 (br s, C9H2), 79.10 (br s, C8H2), 86.20 (br s, C12H), 89.30 (br s, 
C13H), 97.41 (s, C11), 106.23 (s, C14), 121.63 (s, C2H), 123.60 (s, C4), 135.20 (s, C3H), 151.30 
(s, C1). 
 
Figure 2. Numbering used for NMR assignment. 
 
2.6. Catalytic tests 
All catalytic reactions were performed in Schlenk tubes, with strong magnetic stirring, and 
warm oil bath. The percentage of conversion and the selectivity were measured by relative 
integration of 1H NMR signals. Experiments have been done in duplicate, and the values 
given are the mean values (generally ± 2).  
Catalyzes with the Ru complexes M-Ru, G1-Ru12, G2-Ru24, and G3-Ru48: in the Schlenk tube 
were mixed 1 mL of water, 3 mL of isopropanol, 0.11 mL (1.0 mmol) of phenylacetylene, 5.0 
10-2 mmol of preformed Ru complex (31.0 mg of M-Ru, 36.0 mg of G1-Ru12, 38.5 mg of G2-
Ru24, and 39.6 mg of G3-Ru48). These mixtures afforded a single phase in all cases. They 
were stirred for 24 or 48h at 90°C.  
Catalyzes with the complexes formed in situ: in the Schlenk tube were mixed 1 mL of water, 3 
mL of isopropanol, compounds M, G1, G2, or G3, and [RuCl2(p-cymene)]2, using 1.1 equiv. 
of PTA for 1 equiv. of Ru. The mixture was left to react for 15 min at room temperature, then 
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phenylacetylene (100 equiv.), and H2SO4 (co-catalyst, 10 equiv.) were added, then the heating 
was started.  
Recycling experiment: the first run was carried out in the conditions used for the complexes 
formed in situ (with M and G1), followed by heating for 17 h at 90°C. At the end of the first 
run, an extraction was made with diethylether. A new portion of isopropanol and of 
phenylacetylene was added, and the catalysis was again carried out at 90°C for 17 h (second 
run). 
2.7. Interactions with DNA 
The complexes M-Ru, G0-Ru6, G1-Ru12, G2-Ru24, and G3-Ru48 were first evaporated under 
vacuum for a long time (48h) to eliminate traces of organic solvents, then they were 
tentatively dissolved in phosphate buffer. G3-Ru48 was insoluble and was discarded at this 
step. G1-Ru12 and G2-Ru24 have a low solubility in these conditions, but they were used, as 
well as M-Ru and G0-Ru6 (which are fairly soluble) for interaction with supercoiled DNA. 
One microgram of the pBluescript KSII plasmid (3Kbp; StratageneTM) was added to 20 µL of 
10 mM phosphate buffer solution at pH 7.0 and diluted with the appropriate amount of a 
freshly prepared solution of the ruthenium complexes in the same phosphate buffer to achieve 
the desired stoichiometry between the nucleobase and the ruthenium complex. The reaction 
mixtures were then incubated for 14 h at 37 °C in the dark, and 10 µL sample-aliquots were 
withdrawn and analyzed by electrophoresis in 1% agarose-TAE gels. DNA bands were 
visualized by staining with ethidium bromide and photographed under UV light. The Ri value 
(metal to base molar ratio at the onset of the incubation) at which complete transformation of 
the supercoiled to relaxed form of the plasmid was registered for each active compound. 
The result of the interactions was determined by DNA mobility shift assays, and compared 
with the results of cisplatin (cis-[PtCl2(NH3)2]). Analogous experiments were carried out by 
dissolving first the complexes in a small quantity of DMSO, then adding these solutions to 
phosphate buffer. All the compounds were soluble in these conditions, but the results of the 
interaction with supercoiled DNA were analogous than in the previous cases. 
 
3. Results and discussion 
3.1. Catalysis. 
As a test reaction, we have chosen the catalytic hydration of alkynes. This reaction is 
frequently encountered in the literature, and different types of catalysts have been used, in 
particular mercury, but also less toxic metals such as gold, platinum and palladium, and 
mainly ruthenium [29]. We have previously reported the use of the preformed Ru complexes 
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shown in Figure 1 for catalyzing the hydration of phenyl acetylene, and the isomerization of 
1-octan-3-ol to 3-octanone. The latter experiment displayed a nice positive dendritic effect, 
i.e. an increase of the efficiency of the catalysis when the generation (size) of the dendrimer 
increased. This effect was not due to a larger number of catalytic entities, as the number of 
Ru-PTA entities was kept constant, by comparing the efficiency of 1 equiv. of G3-Ru48 to that 
of 2 equiv. of G2-Ru24, or 4 equiv. of G1-Ru12, or 48 equiv. of M-Ru. However, the hydration 
of phenyl acetylene was more difficult, necessitated a prolonged heating (48 h at 90°C), and a 
negative dendritic effect in the percentage of conversion was observed on going from G1-Ru12 
to G3-Ru48, albeit a slight improvement in the selectivity was observed [27]. Thus we decided 
to modify the conditions of the catalyzed hydration of acetylene, to try to get better results 
(Scheme 1).  
It is known that metal-catalyzed hydration of alkynes provides an important route to carbonyl 
compounds [30], with complete atom economy. In general, addition of water to terminal 
alkynes follows Markovnikov’s rule, leading mainly to ketones. In the case of ruthenium 
derivatives used as catalysts for such reactions, the ketones are generally obtained, but the 
anti-Markovnikov product (the aldehyde) was obtained using a Ru catalyst in the presence of 
water [31]. In the case of our preformed dendritic complexes, only small quantities of 
aldehyde were obtained (Scheme 1), and essentially with the smaller catalysts [27].  
 
 
Scheme 1. Catalyzed hydration of phenylacetylene. The type of Ru catalysts, their quantities, 
the temperature, the time, and the selectivity (value of ε) will be given in the next Figures. 
 
In the first experiment, we decided to check the influence of the time of reaction on the 
outcome of the catalysis, using the already synthesized complexes. The conditions applied 
were water/isopropanol 1 mL:3 mL, with phenylacetylene (0.11 mL)/[Ru] 100:5, 
corresponding to 5 equiv. of M-Ru (31.0 mg), 0.4166 equiv. of G1-Ru12 (36.0 mg), 0.2083 
equiv. of G2-Ru24 (38.5 mg), and 0.1416 equiv. of G3-Ru48 (39.6 mg), at 90°C for 24h 
(except with G2-Ru24), and 48 h. In this way, the number of PTA-Ru entities is identical in all 
experiments, whatever the generation of the dendrimer is. It can be seen from Figure 3 that 
the conversion is very low after 24 h, the best result being for G1-Ru12, with 14% of 
conversion. The same tendency is observed after 48 h, with G1-Ru12 being still the most 
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efficient (58% of conversion). Besides, the quantity of aldehyde increases with time, as it is 
not detected after 24 h, but it is low.  
 
 
Figure 3. Percentage of conversion, percentage of ketone, and percentage of aldehyde (ε in 
Scheme 1), from left to right for each preformed catalyst, after 24 h (first row) or 48 h (second 
row), for the catalyzed hydration of phenylacetylene, using 5 mol% of Ru complexes at 90°C. 
Data after 48h from reference [27]. 
 
Searching how to improve the conversion rate, we decided to use a co-catalyst, i.e. H2SO4 (10 
equiv.), which has been already proposed in the hydration of alkynes [32]. The experiment 
was carried out with G1-Ru12 (using only 1 mol% instead of 5 in the previous experiment) at 
90°C for 17 h, and afforded 26% of conversion (14% after 24 h without H2SO4 and using 5 
mol% of G1-Ru12). Thus, the use of a co-catalyst really improved the conversion, but still the 
result was not totally satisfying with the complexes synthesized ex situ (preformed), thus we 
decided to modify the protocol by producing the complexes in situ, instead of using already 
prepared complexes. Several examples in the literature have already reported the comparison 
between preformed and in situ formed complexes for catalysis [33-37]. The in situ formation 
of a catalyst is most generally applied to simplify the process, and in most cases, there is no 
difference in the catalytic activity between pre-formed and in situ generated catalysts. 
However, in some cases the in situ generated catalysts outperform the preformed catalysts. 
Diverse explanations have been proposed, in particular the limited stability of the complexes 
[38-40], which is not the case of our complexes.  
The first experiment was carried out with G1, to which was added in situ [RuCl2(p-cymene)]2 
(1.1 equiv. PTA for 1 Ru). H2SO4 and phenylacetylene were added 15 min after at room 
temperature. Then the mixture was heated for 17 h at 90°C. The conversion was 68%, to be 
compared with the experiment carried out with G1-Ru12 in the same conditions (26%). This 
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result is surprising, but it has been shown previously that the in situ preparation of a catalyst 
from phosphines and [RuCl2(p-cymene)]2 was more efficient for the polymerization of 
acetylene than the corresponding preformed complex. This effect was tentatively assigned to 
the presence of free phosphines [41]. In our case, we used a slight excess of phosphine for the 
in situ process. Such property when using the dimer of ruthenium has been emphasized in the 
conclusion of a review “catalytic systems generated in situ from [RuCl2(p-cymene)]2 dimer 
and stable, commercially available ligand precursors usually display a similar or even higher 
(catalytic) activity” [42].   
In view of these results, all the forthcoming experiments were carried out by forming the 
complexes in situ, and using 10 equiv. of co-catalyst (H2SO4). In order to try to optimize both 
the time and the temperature, three experiments were carried out at 55°C for 4 h, at 70°C for 
17.5 h, and at 90°C for 17 h, with M (+Ru) and G1 (+12 Ru). For both compounds, the 
percentage of conversion was very low after 4 h at 55°C (2%), but the products obtained were 
very different. With the monomer M, the main product of the catalysis is the aldehyde (52% 
selectivity), whereas with the dendrimer G1, the only product obtained is the ketone (100% 
selectivity). At 70°C for 17.5 h, the conversion is still very low, with a slightly better result 
obtained with the dendrimer (13% versus 10%). High conversions were observed only at 
90°C for 17 h. In this case, the conversion was better with the monomer (83%) than with the 
dendrimer (64%). These values are better than the results obtained when using 5% of 
[RuCl2(p-cymene){P(CH2OH)3}] (instead of 1% of catalyst in our work) for the hydration of 
phenylacetylene at 90°C for 24h (instead of 17h), which afforded the corresponding ketone in 
89% yield [43]. 
Whatever the conditions, the only product of the catalysis was the ketone, when using the 
dendrimer, whereas a certain percentage of aldehyde was obtained in all cases with the 
monomer, even if this percentage decreased when the temperature increased (Figure 4).  
 
 
Figure 4. Percentage of conversion, percentage of ketone, and percentage of aldehyde (from 
left to right for each catalyst) for the catalyzed hydration of phenylacetylene, carried out at 
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55°C (for 4 h), 70°C (for 17.5 h), and 90°C (for 17 h), using the monomer (M) plus 1/2 
[RuCl2(p-cymene)]2 (M + Ru), or the first generation dendrimer (G1) plus 6 [RuCl2(p-
cymene)]2 (G1 + 12 Ru), using 1 mol% of Ru, 1.1 mol % of PTA ligand, and 10 mol % of 
H2SO4 as co-catalyst in both cases. 
 
A previous experiment has demonstrated the importance of steric hindrance on the ratio 
aldehyde/ketone, with an increased steric hindrance favoring the formation of ketone [31]. 
This is coherent with our work, in which the aldehyde is observed essentially with the 
monomer (the least hindered complex), and traces of aldehyde are observed with the first 
generation dendrimer (the least hindered dendrimer). The mechanism proposed for the 
hydration of alkynes shows that obtaining the ketone is straightforward, with as single 
intermediate the complexation by the Ru of the triple bond, to which water adds directly. On 
the contrary, obtaining the aldehyde necessitates four intermediates, and in particular the 
rearrangement of the complex of the triple bond to a vinylidene complex [31]. One may 
consider that increasing the temperature should increase the rate of the straightforward 
addition of water to the complex of the triple bond, at the expense of its isomerization to the 
vinylidene complex, thus decreasing the amount of aldehyde, as we observed. Recent 
advances have shown the importance of heterocyclic phosphine ligands having a nitrogen 
capable of inner-sphere hydrogen bonding in the catalytic intermediates to lead to the 
aldehydes [44,45], but the nitrogen atoms in our compounds are not in the appropriate 
location to induce such phenomenon.  
As slightly better results were obtained with the dendrimer than with the monomer at 70°C, 
we decided to study the evolution of the percentage of conversion with time, using the in situ 
Ru complexes of M, G1, and G2 as catalysts. An almost linear increase of the percentage of 
conversion with time (0 to 109 h) was observed in all cases. The efficiency increased in the 





Figure 5. Evolution of the percentage of conversion with time for the catalyzed hydration of 
phenylacetylene, using 1 mol% of Ru, 1.1 mol% of PTA ligand (M, G1, G2), and 10 mol% of 
H2SO4 as co-catalyst, at 70°C. 
 
These results are an illustration of the so called “dendritic effect”, which corresponds to a 
non-linear variation of a property with the generation of the dendrimers, which is not fully 
understood [46]. In our case, one may propose that G1 + 12Ru is the best compromise 
between the probability for a substrate to interact with a catalytic site, and its possibility to 
access to the catalytic site. Indeed, if the substrate does not interact with the first catalytic site 
it encounters, it will interact with the second, in close proximity in the case of the dendrimers, 
not with the monomer; this may account for M < G1. On the contrary, if many catalytic sites 
are occupied by a substrate, the access to the remaining free sites might be impossible in the 
case of the larger dendrimers due to steric hindrance; this may account for G2 < M < G1. 
One of the main motivation for using dendrimers as catalysts is the possibility to recover them 
and to reuse them in another catalytic experiment. Up to twelve runs with an identical 
catalytic efficiency have been already observed with phosphorhydrazone dendrimers [10,47]. 
Experiments were carried out with the in situ formed complexes of M and G1, for 17h at 90°C 
for the first run. Then an extraction was made with diethylether. A new portion of isopropanol 
and of phenylacetylene was added, and the catalysis was carried out again at 90°C for 17 h for 
the second run (Figure 6). Surprisingly, the percentage of conversion slightly increased when 
the monomer was reused (from 83 to 87 %), whereas it slightly decreased in the case of the 
G1 dendrimer (from 64 to 57%). Most generally, dendrimers are easier to recover than 
monomers, as they are slightly less soluble, due to their large size. In the particular case here, 
the recovery is done in a two phase process, by adding ether to the mixture of 
water/isopropanol. The monomer is fully soluble in water, and not soluble in ether. On the 
contrary, the dendrimer is less soluble in water, and due to its hydrophobic internal structure, 
it is slightly soluble in ether. Thus the monomer is easier to recover than the dendrimer, and 





Figure 6. Recycling experiments for the catalyzed hydration of phenylacetylene. First row: 
first run; second row: second run (recycling). Percentage of conversion, percentage of ketone, 
and percentage of aldehyde (from left to right for each catalyst), after 17h at 90°C, using 1 
mol% of Ru, 1.1 mol% of PTA ligand (M, G1), and 10 mol% of H2SO4 as co-catalyst.  
 
3.2. Interaction with DNA 
Several ruthenium derivatives have been proposed for anti-cancer chemotherapies [48,49], 
almost always designed to mimic the cisplatin drug for targeting DNA, and researches in the 
field are very active, including for PTA, and its derivatives, complexes of Ru [50-53], thus it 
appeared interesting to test all the ruthenium complexes (M-Ru, G1-Ru12, G2-Ru24, and G3-
Ru48) for their possible interaction with DNA. All the catalytic experiments have been carried 
out in mixtures water/isopropanol, in which all these complexes are fairly soluble. However, 
for the biological experiments, it is better to have compounds soluble in pure water or in 
buffers. M-Ru is well soluble in water, G1-Ru12 and G2-Ru24 are poorly soluble in water, and 
G3-Ru48 is totally insoluble in water, and thus has been discarded for the biological 
experiments. In view of the large difference in water solubility between M-Ru and G1-Ru12, 
it appeared important to synthesize an intermediate compound, i.e. the generation zero (G0-
Ru6). This compound is synthesized as were G1-Ru12, G2-Ru24, and G3-Ru48 [27], as shown 
in Scheme 2. Starting from 1-G0, the first step is the reduction of the aldehydes with 
BH3.SMe2, to afford benzylalcohol terminal functions (2-G0). The second step is the 
chlorination of the alcohols with SOCl2, to afford benzylchloride terminal functions (3-G0). 
The third step is the alkylation of one nitrogen of PTA by the benzylchloride, affording G0. 
The Ru complex G0-Ru6 is obtained in the last step, using the dimer [RuCl2(p-cymene)]2. The 
four compounds are in particular characterized by multinuclear NMR. The completion of the 
reactions on all terminal functions is assessed by 1H NMR, which displays different signals on 
going from the aldehydes of 1-G0 (δ CHO = 9.9 ppm), to the benzylalcohols of 2-G0 (δ 
CH2OH = 4.47 ppm), then to the benzylchlorides of 3-G0 (δ CH2Cl = 4.59 ppm), and finally 
to the ammonium of PTA of G0 (δ CH2N = 4.22 ppm). In 31P NMR, two signals are observed 
for G0 and G0-Ru6, corresponding to the cyclotriphosphazene core, and the PTA. The latter 
signal shifted from -83.7 ppm for G0 (free PTA) to -18.1 ppm for G0-Ru6 (complexed PTA), 
showing unambiguously the complexation of PTA with Ru. Dendrimer G0-Ru6 is fairly 





Scheme 2. Synthesis of the dendrimer of generation 0, functionalized by PTA (G0), and of the 
corresponding ruthenium complex (G0-Ru6). 
 
It is well known that the anticancer drug cisplatin binds covalently to DNA, with concomitant 
bending and unwinding of the double helix [54]. Thus, as a first assay, we studied the 
interaction of the Ru complexes with supercoiled DNA, to detect if this interaction could lead 
to the relaxed form of DNA, and in comparison with cisplatin. Such assay is widely used for 
testing potential anti-cancer compounds; it enables testing compounds as a previous 
screening, to further focus on the most interesting ones for in vivo assays. Tests on cell 
cultures only provide another step (rarely conclusive) to assess the utility of a given 
compound as anticancer drug. 
The complexes were first dissolved in phosphate buffer. Compounds M-Ru and G0-Ru6 are 
soluble, dendrimers G1-Ru12, and G2-Ru24 are poorly soluble. Experiments were performed at 
a fixed DNA amount and different concentrations of the Ru complexes were assayed. The Ri 
ratios, expressed as Ru atoms per base of DNA, are indicated in Figure 7. As it is shown, Ri 
values at which the complete conversion of supercoiled (SC) to relaxed DNA (OC) is 






Figure 7. DNA mobility shift assay of Ru complexes (from up to down M-Ru, G0-Ru6, G1-
Ru12, and G2-Ru24) and of cisplatin. SC: supercoiled DNA. OC: open circular DNA. CON: 
plasmid concatemers. The Ri (Ru / DNA base molar ratio) values are shown below for each 
assay. Molecular complex concentrations to achieve the coalescent point for each complex are 
indicated by an arrow. 
 
Ri values are similar for compound G0-Ru6 and cisplatin, while they are increasingly higher 
for M-Ru, G2-Ru24 and G1-Ru12, respectively. The Ri values in Figure 7 are expressed in 
Moles of Ru, as was done in the catalysis experiments, but it is interesting to calculate the 
Moles of compounds at which the coalescence occurred. This molar concentration is 0.065 
mM for M-Ru, 0.0037 mM for G0-Ru6, 0.052 mM for G1-Ru12, and 0.0053 mM for G2-Ru24, 
to be compared to 0.02 mM for cisplatin. Thus, two compounds are more active than cisplatin 
when expressed in molar concentrations (G0-Ru6 and G2-Ru24), but only one (G0-Ru6) 
compares well with cisplatin when considering the concentration in metal (as for the Ri 
values). 
As the poor efficiency (high Ri values) of the largest dendrimers, G1-Ru12, and G2-Ru24, 
might be related to their poor solubility, another experiment was carried out by dissolving first 
the complexes in DMSO, in which all of them are fairly soluble, and then adding this solution 
in the phosphate buffer. All compounds remained soluble in these conditions, but the results 
of the DNA mobility shift assay were not very different from those shown in Figure 7. In 
particular, no real improvement was observed for compounds G1-Ru12, and G2-Ru24. 
 
Conclusion  
The most well-known dendrimers can be often synthesized up to high generations (large size), 
as illustrated by the synthesis of PAMAM dendrimers up to generation 10 [55], of 
phosphorhydrazone dendrimers up to generation 12 [56], and even of triazine dendrimers up 
to generation 13 [57]. In most cases the best properties are obtained with generation 4 to 6, 
but in some cases the first generation is the best, in particular for biological experiments [12]. 
In this paper, we have shown that in different conditions the ruthenium complex (preferably 
formed in situ than preformed) of the first generation dendrimer ended by PTA is the best for 
catalyzing the hydration of phenylacetylene, compared to the corresponding second and third 
generations of the dendrimers, and compared to the monomer. The same family of compounds 
has been tested for unwinding supercoiled DNA. In that case, the generation 0 is the best, 
displaying an efficiency similar to that of cisplatin. 
16 
 
Thus in some cases, smaller is better, but not too small, as the multivalency, which is already 
obtained with generations 0 or 1, offers better results than with a monomer. This is an 
interesting aspect of this work: the synthesis of dendrimers is generally a lengthy process but 
the multivalency effect can be observed even with low generations, easily synthesized, and 
less costly. Furthermore, we have shown that a same family of dendrimers can be useful in 
two very different topics, thus opening new perspectives for dendrimers. 
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